LOCUS       BAB91245                3446 aa            linear   MAM 27-FEB-2009
DEFINITION  Brca2 [Canis lupus familiaris].
ACCESSION   BAB91245
VERSION     BAB91245.3  GI:58801256
DBSOURCE    accession AB043895.5
KEYWORDS    .
SOURCE      Canis lupus familiaris (dog)
  ORGANISM  Canis lupus familiaris
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae;
            Canis.
REFERENCE   1
  AUTHORS   Ochiai,K., Morimatsu,M., Tomizawa,N. and Syuto,B.
  TITLE     Cloning and sequencing full length of canine Brca2 and Rad51 cDNA
  JOURNAL   J. Vet. Med. Sci. 63 (10), 1103-1108 (2001)
   PUBMED   11714026
REFERENCE   2  (residues 1 to 3446)
  AUTHORS   Yoshikawa,Y., Ochiai,K. and Morimatsu,M.
  TITLE     Direct Submission
  JOURNAL   Submitted (26-MAY-2000) Contact:Masami Morimatsu Hokkaido
            University, Laboratory of Animal Experiment for Disease Model,
            Institute for Genetic Medicine; North 15, West 7, Kita-ku, Sapporo
            060-0815, Japan
COMMENT     On Feb 8, 2005 this sequence version replaced gi:20502478.
FEATURES             Location/Qualifiers
     source          1..3446
                     /organism="Canis lupus familiaris"
                     /sub_species="familiaris"
                     /db_xref="taxon:9615"
                     /note="synonym: Canis familiaris"
     Protein         1..3446
                     /name="Brca2"
     Region          996..1030
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          1210..1244
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          1416..1449
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          1519..1552
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          1666..1700
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          1998..2030
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          2067..2100
                     /region_name="BRCA2"
                     /note="BRCA2 repeat; pfam00634"
                     /db_xref="CDD:144287"
     Region          2498..2686
                     /region_name="BRCA-2_helical"
                     /note="BRCA2, helical; pfam09169"
                     /db_xref="CDD:117723"
     Region          2732..2811
                     /region_name="BRCA2DBD_OB1"
                     /note="BRCA2DBD_OB1: A subfamily of OB folds corresponding
                     to the first OB fold (OB1) of the 800-amino acid
                     C-terminal ssDNA binding domain (DBD) of BRCA2 (breast
                     cancer susceptibility gene 2) protein, called BRCA2DBD.
                     BRCA2 participates in homologous...; cd04493"
                     /db_xref="CDD:72965"
     Site            order(2737..2740,2742,2748..2750,2752,2768,2776..2778,
                     2794..2796)
                     /site_type="other"
                     /note="generic binding surface I"
                     /db_xref="CDD:72965"
     Site            order(2744,2755,2758,2763,2766,2769,2801..2804,2806..2807,
                     2810..2811)
                     /site_type="binding"
                     /note="binding surface II"
                     /db_xref="CDD:72965"
     Region          2842..3073
                     /region_name="BRCA2DBD_OB2"
                     /note="BRCA2DBD_OB2: A subfamily of OB folds corresponding
                     to the second OB fold (OB2) of the 800-amino acid
                     C-terminal ssDNA binding domain (DBD) of BRCA2 (breast
                     cancer susceptibility gene 2) protein, called BRCA2DBD.
                     BRCA2 participates in homologous...; cd04494"
                     /db_xref="CDD:72966"
     Site            order(2845..2846,2848,2860,2865,2992,3069,3071..3073)
                     /site_type="other"
                     /note="OB2/OB3 interface [polypeptide binding]"
                     /db_xref="CDD:72966"
     Site            order(2860,2990,3007,3009..3010,3045,3047)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:72966"
     Region          3092..3186
                     /region_name="BRCA2DBD_OB3"
                     /note="BRCA2DBD_OB3: A subfamily of OB folds corresponding
                     to the third OB fold (OB3) of the 800-amino acid
                     C-terminal ssDNA binding domain (DBD) of BRCA2 (breast
                     cancer susceptibility gene 2) protein, called BRCA2DBD.
                     BRCA2 participates in homologous...; cd04495"
                     /db_xref="CDD:72967"
     Site            order(3092,3138,3140,3142,3166)
                     /site_type="other"
                     /note="generic binding surface II"
                     /db_xref="CDD:72967"
     Site            order(3105..3107,3147,3158,3160..3161)
                     /site_type="other"
                     /note="ssDNA binding site [nucleotide binding]"
                     /db_xref="CDD:72967"
     CDS             1..3446
                     /gene="Brca2"
                     /coded_by="AB043895.5:209..10549"
ORIGIN      
        1 mpvgckerpt ffeifktrcn qadlgpisln wfeelsleap pynseptees gykisyepnl
       61 fktpqrkpyn qlastpivfr epiyqqsplk eldkyrldsg kditdskhks cctmkskmdr
      121 andvtsppln sylsespvlr cthvtpqrek svvcgslfht pklmkgqtpk riseslgaev
      181 dsdmswsssl atpptlsstv livrdeevsa avfpndttai fkscfsnhde slkkndrfip
      241 cgpgkenknq reaksqslgn sfgkvnstkd hfvkstpnvl edevhekvld vseeedsfsl
      301 cvpkyktrnl qkiktsktrk nifnetktse ceeakkqmke nkhslvseme pndshpldwn
      361 vthekpfgng tdkiskeivl ssasgcsdlt lsslngaqme ktpllhtsyd qnnsekdlii
      421 tdkectnfit lenswpqisn vpkysektln eeivvnkine gqclesheds vvsvkqaiye
      481 ttliasplqg irksifrire spegmsnamf snnmtnpnfk epeasesgle khticsqked
      541 slctssiddg swpatikhts valknlglis slkkktkkfi yvindetsnq glktqkdqes
      601 rlinlstqfe anafegpltf tnadsgllhs ssikknclqn dsekpalslt ssfgtilrkv
      661 ssngasspnn kiisqdpdyk eakinkkkle sfittetdcl sslqekhwed dakkqrvsdi
      721 kekvlptvsh ppvphseveg sdihfqspes fsfdcdntsl ltpssrdsps slvvmsrgke
      781 sykiseklkc knhetgfelt knipmeknqd ihvlnadskn akllstekhi tvasssvkvq
      841 fnqnanltti qkdqkettli skitvnpnse elfpddennf vlkitnesnt pvlgntkelh
      901 dsnlccvrds vpknstmvvc tdlddkqtak vsimkdcyss siddlternr stikqqlkmt
      961 ldqdsksdit sdivrksngn sdymdnwarl sdpisnhsfe ngfktasnke iklsennirk
     1021 skmlfkdiee hyptnlacle ivntsslesq kkpskshald pqsiniisgf vqnstyvsds
     1081 esghtapptl slkqdfdsnr nltpsqkaei telstilees gsqfeftqfr kpshiiqknp
     1141 fempenqlti lnstskewkd ddlhlttnap sisqvdskks egiiggkqkf aclsrtscnr
     1201 sasgystdkn evefrgfysa rgtklnvgse alqkakklfs dlenineets vevdrsfsss
     1261 kyndsvsmiq iedcndknln eknnkcrlil qnniemttdi fveeytesyr rntenegnqc
     1321 tdagrntcns esdgsdsskn dtvyiheeen glpcidqhni dlklfsqfmk egntqikegl
     1381 sdltclevmk aeetshvtms nkqqltantg qnikdfdtfy lsfqtasrkn irvskeslnk
     1441 arsllnqkwt eeelnnfsds lnsellpgid ikktdisnhe vienterkdk itkesdligt
     1501 enillilqqr peskikkike savlgfhtas gkkieitkes ldkvknlfee keqdnseitn
     1561 fshrgakmsk dreeckdgre lacgtteitt tpeyeethss lekkklvsne iaalrprlls
     1621 dnlykqtenl kisdhasqkv dvhenteket akkptmytnq stysaiensp ltfytghgrk
     1681 isvseaslfe akkwlregew ddqserinaa kvnclkeypd dyvenpscgn ssnsaitend
     1741 knhlsekqgs tylsnstmsn sysyhpgfch ssevynksey lsrskidnsg iepviknire
     1801 rknigfseim spgreadtdp qsvnedicve klatnssckn kntaikvais dsnnfntiqk
     1861 lnsdsnnsvp aystvnskrv fvahqtkvte gftdncsmvt kqntksksdt chaeivadyp
     1921 kalddseaif pnslgaiecs pshkvfadiq seqtsqlnqs msglekvset ppcqinskts
     1981 drcelprgkl pksvsytnac gifstasgks vqvsdaaiqk arevfskled sakqlfpevs
     2041 lkdneehsek ftneentviy tsqnllssaf sgfrtasgkq vpvsesalck vkgmleefnl
     2101 irtesclqhs stsrqdvskm pppscigkrt pehsrnskld kacnkefrls sncnnqsgss
     2161 enhhsikvsp cpsqlkrdkp qllvgskgsl venihplgke qalpknikte igkaetfpnl
     2221 pvktniefcs tyskdpenyf etetveiaka fmedgeltds ellshakhfv ftcqntkemv
     2281 llnsrigkrr gdalvsvgep pikrnllnef driiknqets lkaskstpdg ilkdrslfmh
     2341 hislepiscg pfrtteerqe iqnpnftapg qeflpkshfy ehlaseksss nlsvsrqpfc
     2401 mvpatgnekr rhliapgkpv kvfvppfktk shfhrdeqci skntkleknk qnskdidelg
     2461 sgdseknind sgihqlkknn snqaatiift knekepldli tnlqnardiq dmrikkkqrq
     2521 hifpqpgsly laktstlpri slreavegrv psacshkqly mygvskhcvk insknaesfq
     2581 fhaqdyfgke glwsgegiql adggwlipsn dgkigkeefy ralcdtpgvd pncisrvwvy
     2641 nhyrwiiwkl aamefafpke fanrclsper vllqlkyryd veidksrrsa ikkimerddt
     2701 aaktlvlcis eiisssadis etsssktssv gtkkvgiiel tdgwyaikaq ldppllalvk
     2761 ngrltvgqki tihgaelvgs pdactpleap eslmlkisan strpacwytk lgfspdprpf
     2821 plplsslfsd ggnvgcvdvv vqraypiqwm ertpsglcif rnereeekea tkyaeiqqkk
     2881 levlfnkiqa efekndenit kqcipscalt rqqicalqdg aelyeavtna pdpsdlegyf
     2941 seeqlralnn hrqmlndkkq aqiqlefkka mesaeqgeqi lprdvttvwk lriisyrkke
     3001 kdsvtlsiwr pspdlyslli egkryriyhl aasqsksksg kantqltatk ktqyqqlpas
     3061 deilsqvyqp replyfnkll dpdfqppcse vdligfvvsv vkkiglapvv ylsdechnll
     3121 aikfwtdfne diikpytlia asnlqwrpea ksgiptlfag dfsrfsaspk eehfqetfhk
     3181 mkntvenigm fyndaenklv hilnandpkl stptkdyase phtaqivlgi gnkflmsspn
     3241 nemnyqspls lckpkeksvp ipgstqmtsk syckeekemd dpktckkrra ldflsrvplp
     3301 psvspictfv spaaqkafqp prscgtkyet lmkkelnspq mtprkfndls llesdsiade
     3361 elamintqal llgspgehql vsvsdstrta ptsskdylgl krhstapgvr gpespqactr
     3421 kreprvqnts dlkrtslrlq rqqtqk
//

